1-5 of 5
Hongxia Zhang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 3091: Discovery and development of a potent and highly selective WEE1 inhibitor IMP7068

Free
Sui Xiong Cai, Ning Ma, Xiaozhu Wang, Yangzhen Jiang, Hongxia Zhang, Mingchuan Guo, Ruiyu Zhou, Ye Edward Tian
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 3091.
https://doi.org/10.1158/1538-7445.AM2023-3091
Published: 04 April 2023
View article titled, Abstract 3091: Discovery and development of a potent and highly selective WEE1 inhibitor IMP7068
Journal Articles

Targeting BCAT1 Combined with α-Ketoglutarate Triggers Metabolic Synthetic Lethality in Glioblastoma

Available to Purchase
Bo Zhang, Hui Peng, Mi Zhou, Lei Bao, Chenliang Wang, Feng Cai, Hongxia Zhang, Jennifer E. Wang, Yanling Niu, Yan Chen, Yijie Wang, Kimmo J. Hatanpaa, John A. Copland, Ralph J. DeBerardinis, Yingfei Wang, Weibo Luo
Journal: Cancer Research
Cancer Res (2022) 82 (13): 2388–2402.
https://doi.org/10.1158/0008-5472.CAN-21-3868
Published: 05 July 2022
View article titled, Targeting BCAT1 Combined with α-Ketoglutarate Triggers Metabolic Synthetic Lethality in Glioblastoma
Open the PDF for Targeting BCAT1 Combined with α-Ketoglutarate Triggers Metabolic Synthetic Lethality in Glioblastoma in another window
Includes: Supplementary data
Journal Articles

Mevalonate Blockade in Cancer Cells Triggers CLEC9A+ Dendritic Cell-Mediated Antitumor Immunity

Available to Purchase
Feifei Xu, Zining Wang, Hongxia Zhang, Jiemin Chen, Xiaojuan Wang, Lei Cui, Chunyuan Xie, Mengyun Li, Fang Wang, Penghui Zhou, Jinyun Liu, Peng Huang, Xiaodong Xia, Xiaojun Xia
Journal: Cancer Research
Cancer Res (2021) 81 (17): 4514–4528.
https://doi.org/10.1158/0008-5472.CAN-20-3977
Published: 01 September 2021
View article titled, Mevalonate Blockade in Cancer Cells Triggers CLEC9A+ Dendritic Cell-Mediated Antitumor Immunity
Open the PDF for Mevalonate Blockade in Cancer Cells Triggers CLEC9A+ Dendritic Cell-Mediated Antitumor Immunity in another window
Includes: Supplementary data
Journal Articles

Abstract OT2-04-02: CheckMate 7A8: A phase 2 trial of nivolumab + abemaciclib or palbociclib + anastrozole in postmenopausal women with ER+, HER2−primary breast cancer

Free
Sara Tolaney, Guy Jerusalem, Roberto Salgado, Xiaochun Liu, Tian Chen, Hongxia Zhang, Mustimbo Roberts, Dimitrios Zardavas, Aleix Prat
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): OT2-04-02.
https://doi.org/10.1158/1538-7445.SABCS19-OT2-04-02
Published: 15 February 2020
View article titled, Abstract OT2-04-02: CheckMate 7A8: A phase 2 trial of nivolumab + abemaciclib or palbociclib + anastrozole in postmenopausal women with ER+, HER2−primary breast cancer
Journal Articles

Abstract C67: Hypoxia‐inducible factor‐2α regulates macrophage functions in both acute and tumor inflammation

Free
Hongxia Zhang Imtiyaz, Emily P. Williams, Michele M. Hickey, Shetal A. Patel, Amy C. Durham, Li‐Jun Yuan, Brian Keith, M. Celeste Simon
Journal: Cancer Research
Cancer Res (2009) 69 (23_Supplement): C67.
https://doi.org/10.1158/0008-5472.FBCR09-C67
Published: 28 October 2014
View article titled, Abstract C67: Hypoxia‐inducible factor‐2α regulates macrophage functions in both acute and tumor inflammation